{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20423107", "DateCompleted": {"Year": "2010", "Month": "06", "Day": "25"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1021/np100228d"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "73", "Issue": "5", "PubDate": {"Year": "2010", "Month": "May", "Day": "28"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "The alternative medicine pawpaw and its acetogenin constituents suppress tumor angiogenesis via the HIF-1/VEGF pathway.", "Pagination": {"StartPage": "956", "EndPage": "961", "MedlinePgn": "956-61"}, "Abstract": {"AbstractText": ["Products that contain twig extracts of pawpaw (Asimina triloba) are widely consumed anticancer alternative medicines. Pawpaw crude extract (CE) and purified acetogenins inhibited hypoxia-inducible factor-1 (HIF-1)-mediated hypoxic signaling pathways in tumor cells. In T47D cells, pawpaw CE and the acetogenins 10-hydroxyglaucanetin (1), annonacin (2), and annonacin A (3) inhibited hypoxia-induced HIF-1 activation with IC(50) values of 0.02 microg/mL, 12 nM, 13 nM, and 31 nM, respectively. This inhibition correlates with the suppression of the hypoxic induction of HIF-1 target genes VEGF and GLUT-1. The induction of secreted VEGF protein represents a key event in hypoxia-induced tumor angiogenesis. Both the extract and the purified acetogenins blocked the angiogenesis-stimulating activity of hypoxic T47D cells in vitro. Pawpaw extract and acetogenins inhibited HIF-1 activation by blocking the hypoxic induction of nuclear HIF-1alpha protein. The inhibition of HIF-1 activation was associated with the suppression of mitochondrial respiration at complex I. Thus, the inhibition of HIF-1 activation and hypoxic tumor angiogenesis constitutes a novel mechanism of action for these anticancer alternative medicines."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677, USA."}], "Identifier": [], "LastName": "Coothankandaswamy", "ForeName": "Veena", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Yang", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mao", "ForeName": "Shui-Chun", "Initials": "SC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Morgan", "ForeName": "J Brian", "Initials": "JB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mahdi", "ForeName": "Fakhri", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jekabsons", "ForeName": "Mika B", "Initials": "MB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nagle", "ForeName": "Dale G", "Initials": "DG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "Yu-Dong", "Initials": "YD"}], "GrantList": [{"GrantID": "R01 CA098787-05A2", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "NA16RU1496", "Agency": "PHS HHS", "Country": "United States"}, {"GrantID": "R01 CA098787-04", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "C06 RR014503", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "CA98787", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P20RR021929", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "P20 RR021929", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "C06 RR-14503-01", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA098787", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R56 CA098787-05A1", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R56 CA098787", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acetogenins"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucose Transporter Type 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoxia-Inducible Factor 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Endothelial Growth Factors"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Acetogenins"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asimina"}, {"QualifierName": [], "DescriptorName": "Complementary Therapies"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["analysis", "drug effects", "genetics"], "DescriptorName": "Glucose Transporter Type 1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hypoxia-Inducible Factor 1"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neovascularization, Physiologic"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["analysis", "drug effects", "genetics"], "DescriptorName": "Vascular Endothelial Growth Factors"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. J. Clin. Oncol. 2000;18:2505\u20132514.", "ArticleIdList": ["10893280"]}, {"Citation": "McLaughlin JL. J. Nat. Prod. 2008;71:1311\u20131321.", "ArticleIdList": ["18598079"]}, {"Citation": "Cuendet M, Oteham CP, Moon RC, Keller WJ, Peaden PA, Pezzuto JM. Pharm. Biol. 2008;46:3\u20137."}, {"Citation": "Ahammadsahib KI, Hollingworth RM, McGovren JP, Hui YH, McLaughlin JL. Life Sci. 1993;53:1113\u20131120.", "ArticleIdList": ["8371627"]}, {"Citation": "Weidemann A, Johnson RS. Cell Death Differ. 2008;15:621\u2013627.", "ArticleIdList": ["18259201"]}, {"Citation": "Rankin EB, Giaccia AJ. Cell Death Differ. 2008;15:678\u2013685.", "ArticleIdList": ["PMC3050610", "18259193"]}, {"Citation": "Brahimi-Horn MC, Pouyss\u00e9gur J. J. Cell Sci. 2009;122:1055\u20131057.", "ArticleIdList": ["19339544"]}, {"Citation": "Semenza GL. Drug Discov. Today. 2007;12:853\u2013859.", "ArticleIdList": ["17933687"]}, {"Citation": "Poon E, Harris AL, Ashcroft M. Expert Rev. Mol. Med. 2009;11:e26.", "ArticleIdList": ["19709449"]}, {"Citation": "Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, Katschinski DM, Wenger RH. Oncogene. 2003;22:3213\u20133220.", "ArticleIdList": ["12761491"]}, {"Citation": "Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao Y, Li CY, Dewhirst MW. Cancer Cell. 2005;8:99\u2013110.", "ArticleIdList": ["16098463"]}, {"Citation": "U.S. NIH database   [accessed March 20, 2010].   http://www.clinicaltrials.gov/ct2/search."}, {"Citation": "Hodges TW, Hossain CF, Kim YP, Zhou YD, Nagle DG. J. Nat. Prod. 2004;67:767\u2013771.", "ArticleIdList": ["15165135"]}, {"Citation": "Zhong H, Agani F, Baccala AA, Laughner E, Rioseco-Camacho N, Isaacs WB, Simons JW, Semenza GL. Cancer Res. 1998;58:5280\u20135284.", "ArticleIdList": ["9850048"]}, {"Citation": "Ferrara N, Mass RD, Campa C, Kim R. Annu. Rev. Med. 2007;58:491\u2013504.", "ArticleIdList": ["17052163"]}, {"Citation": "Liu Y, Veena CK, Morgan JB, Mohammed KA, Jekabsons MB, Nagle DG, Zhou YD. J. Biol. Chem. 2009;284:5859\u201368.", "ArticleIdList": ["PMC2645834", "19091749"]}, {"Citation": "Nagle DG, Zhou YD. Curr. Drug Targets. 2006;7:355\u2013369.", "ArticleIdList": ["PMC2908043", "16515532"]}, {"Citation": "Lin X, David CA, Donnelly JB, Michaelides M, Chandel NS, Huang X, Warrior U, Weinberg F, Tormos KV, Fesik SW, Shen Y. Proc. Natl. Acad. Sci. U.S.A. 2008;105:174\u2013179.", "ArticleIdList": ["PMC2224181", "18172210"]}, {"Citation": "Mohammed KA, Hossain CF, Zhang L, Bruick RK, Zhou YD, Nagle DG. J. Nat. Prod. 2004;67:2002\u20132007.", "ArticleIdList": ["PMC2910713", "15620241"]}, {"Citation": "Newman DJ, Cragg GM. J. Nat. Prod. 2007;70:461\u2013477.", "ArticleIdList": ["17309302"]}, {"Citation": "Hamanaka RB, Chandel NS. Curr. Opin. Cell Biol. 2009;21:894\u2013899.", "ArticleIdList": ["PMC2787901", "19781926"]}, {"Citation": "Waechter AI, Hocquemiller R, Laurens A, Cav\u00e9 A. Nat. Prod. Lett. 1997;10:205\u2013212."}, {"Citation": "McCloud TG, Smith DL, Chang CJ, Cassady JM. Experientia. 1987;43:947\u2013949.", "ArticleIdList": ["3622737"]}, {"Citation": "Lieb F, Nonfon M, Wachendorff-Neumann U, Wendisch D. Planta Med. 1990;56:317\u2013319.", "ArticleIdList": ["17221428"]}, {"Citation": "Zhou YD, Kim YP, Li XC, Baerson SR, Agarwal AK, Hodges TW, Ferreira D, Nagle DG. J. Nat. Prod. 2004;67:2063\u20132069.", "ArticleIdList": ["PMC2914555", "15620252"]}]}], "History": [{"Year": "2010", "Month": "4", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "4", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "6", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "5", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20423107", "NIHMS200348", "PMC2890309", "10.1021/np100228d"]}}], "PubmedBookArticle": []}